innovent glp 1 π¨π³ #Innovent Biologics' U.S. subsidiary, Fortvita Biologics, has registered a Phase clinical trial for the small-molecule GLP-1 receptor agonist #IBI3032 γ https://t.co/SL71xXprpZ. The Phase 1 trial plans to enroll 32 healthy EASD 2024: Innovent shows off
Pay in 4 interest-free payments of $6.22 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Nov 10 - Nov 15









:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)












